Abstinence-only programs for HIV infection prevention in high-income countries
Evidence Summaries
Evidence Summaries
Level of Evidence = C
A Cochrane review 1 included 13 studies with a total of 15,940 subjects. Six trials were cluster randomised. All included studies enrolled ethnically diverse youth in the US. Seven programs were school-based, two were community-based, and one was delivered in family homes. The trials compared abstinence-only programs to various control groups (e.g., "usual care," no intervention). Median final follow-up occurred 17 months after baseline. Results showed no indications that abstinence-only programs can reduce HIV risk as indicated by self-reported biological and behavioral outcomes. Compared to various controls, the evaluated programs consistently did not affect incidence of unprotected vaginal sex, frequency of vaginal sex, number of partners, sexual initiation, or condom use.
Comment: The quality of evidence is downgraded by indirectness (the homogeneity of the trial populations) and the probable self-reporting bias.
References
References
1. Underhill K, Operario D, Montgomery P. Abstinence-only programs for HIV infection prevention in high-income countries. Cochrane Database Syst Rev 2007 Oct 17;(4):CD005421. [PMID:17943855]
Copyright © 2019 Duodecim Medical Publications Limited.
Abstinence-only programs for HIV infection prevention in high-income countries is a sample topic from the Evidence-Based Medicine Guidelines.
To view other topics, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Complete Product Information.
Citation
"Abstinence-only Programs for HIV Infection Prevention in High-income Countries." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451087/all/Abstinence_only_programs_for_HIV_infection_prevention_in_high_income_countries.
Abstinence-only programs for HIV infection prevention in high-income countries. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/451087/all/Abstinence_only_programs_for_HIV_infection_prevention_in_high_income_countries. Accessed December 9, 2019.
Abstinence-only programs for HIV infection prevention in high-income countries. (2019). In Evidence-Based Medicine Guidelines. Available from https://evidence.unboundmedicine.com/evidence/view/EBMG/451087/all/Abstinence_only_programs_for_HIV_infection_prevention_in_high_income_countries
Abstinence-only Programs for HIV Infection Prevention in High-income Countries [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2019 December 09]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451087/all/Abstinence_only_programs_for_HIV_infection_prevention_in_high_income_countries.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Abstinence-only programs for HIV infection prevention in high-income countries
ID - 451087
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451087/all/Abstinence_only_programs_for_HIV_infection_prevention_in_high_income_countries
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -